Endomyocardial biopsy: a 21st century diagnostic tool

Area of Science:

• Cardiology
• Pathology

Background:

• The diagnostic utility of Endomyocardial Biopsy (EMB) is frequently debated, with claims that advanced cardiovascular imaging techniques offer comparable results without invasive risks.
• While cardiovascular imaging has significantly advanced, EMB is not without risks, especially when performed by less experienced practitioners.

Discussion:

• Despite risks, EMB performed by experts in specialized centers can reveal unexpected diagnoses.
• It can confirm or exclude suspected conditions, providing crucial diagnostic information.
• Even with non-specific findings in collected samples, EMB may indicate multifocal cardiac disease missed by imaging.

Key Insights:

• EMB offers unique diagnostic capabilities beyond imaging, particularly for unexpected or multifocal cardiac conditions.
• The expertise of the medical team and the center's specialization are critical for maximizing EMB's diagnostic yield and safety.
• EMB plays a vital role in confirming or refuting diagnoses, contributing significantly to patient management.

Outlook:

• Further research may refine EMB techniques and patient selection criteria to enhance its safety and efficacy.
• Integration of EMB findings with advanced imaging may lead to more comprehensive cardiac diagnoses.
• Continued evaluation of EMB's role in specific complex cardiac pathologies is warranted.